Reunert Ltd buy krebskrebs
Start price
30.11.20
/
50%
€2.14
Target price
30.11.21
€3.00
Performance (%)
22.43%
End price
01.12.21
€2.62
Summary
This prediction ended on 01.12.21 with a price of €2.62. The BUY prediction by krebskrebs finished with a performance of 22.43%. A total of €0.11 was paid as dividends for this prediction. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Reunert Ltd | 0.658% | 0.658% | 6.993% | 15.038% |
iShares Core DAX® | 2.594% | -1.861% | 13.242% | 16.867% |
iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% | 45.898% |
iShares Nikkei 225® | 0.687% | -8.704% | 17.510% | 2.760% |
iShares S&P 500 | 2.209% | -1.988% | 27.632% | 42.955% |
Comments by krebskrebs for this prediction
In the thread Reunert Ltd diskutieren
Buy mit Kursziel 3,0
In the thread Trading Reunert Ltd
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten